English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Pacific Research Institute
Patient Daily
| Nov 18, 2025
Pacific Research Institute CEO: 340B misuse is 'reducing competition, narrowing patient choices, and driving costs up'
Trending
+
Pharmaceuticals
Patient Daily
| Jan 7, 2026
PhRMA warns of cancer drug markups, 340B program profiteering
+
Pharmaceuticals
Patient Daily
| Jan 12, 2026
Six major FDA drug decisions expected in early 2026
+
Pharmaceuticals
Patient Daily
| Jan 7, 2026
Big pharma leads Q4 biopharma M&A as smaller biotech deals gain momentum
+
Pharmaceuticals
Patient Daily
| Jan 7, 2026
Pfizer leads U.S. drugmakers in planned price increases for 2026
